泌尿系感染大肠埃希菌的交叉耐药和相关耐药  

Cross Resistance and Associated Resistance of Urinary Tract Infection caused by Escherichia

作　　者：李秋荣[1] 颜秉兴[1] 李建军[1] 

机构地区：[1]濮阳市油田总医院,河南濮阳457001

出　　处：《实用医技杂志》2008年第9期1098-1100,共3页Journal of Practical Medical Techniques

摘　　要：目的:通过对泌尿系感染大肠埃希菌的交叉耐药和相关耐药调查,使临床医生进一步了解该菌的耐药状况,了解本地区的耐药模式。方法:细菌鉴定采用API20E,药敏试验采用纸片扩散法,同一种药物按耐药和敏感分为两组。结果:交叉耐药和相关耐药分别计算可更直接观察细菌的耐药状况,耐药菌株对其他抗生素的耐药性与其敏感菌株相比耐药性增高明显。常见的耐药模式为氨苄西林/复方新诺明;氨苄西林/复方新诺明/氟喹诺酮类。产ES-BL大肠埃希菌占37.0%。哌拉西林/他唑巴坦、呋喃妥因和亚胺培南耐药率分别为19.7%、15.4%、0%。结论:加强交叉耐药和相关耐药调查有助于医生选用正确的治疗方式。哌拉西林/他唑巴坦、呋喃妥因和亚胺培南是本地区治疗泌尿系感染大肠埃希菌最有效的药物。Objective To investigate the cross-resistance and associated resistance of urinary tract infection caused by Escherichia coli,further so as to guide the clinician comprehend resistant condition and resistant modes of Escherichia coli in our area.Methods Identification of bacteria was conducted with API20E.The antimicrobial susceptibility of bacteria was determined using the disc diffusion method.The identical drug is dividided into two groups according to sensitivity and resistance.Results To part calculati...

关 键 词：交叉耐药 相关耐药 泌尿系感染 大肠埃希菌 

分 类 号：R446.5[医药卫生—诊断学]